EGFR and mesothelioma: Lately, vascular endothelial growth factor receptor (VEGFR) and the epidermal growth factor receptor (EGFR) have been reported as potential targets for anticancer therapies [16,17,18]; its overexpression in mesothelioma has been also reported [14,19,20,21].